Related Experiment Videos
[Multicentric Castleman's disease. Current aspects of pathogenesis and treatment]
1Sección de Oncología Médica, Hospital General Universitari Vall d'Hebron, Barcelona.
Sangre
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Biochar application and summer temperatures reduce N2O and enhance CH4 emissions in a Mediterranean agroecosystem: Role of biologically-induced anoxic microsites.
The Science of the total environment·2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
[MLL rearrangements in acute leukemias].
Sangre·2000